ContributorsPublishersAdvertisers

Dr. Verstovsek on the Benefit of JAK Inhibitor Combos in Myelofibrosis

onclive.com
 2021-10-13

Srdan Verstovsek, MD, PhD, discusses the benefit of drug combinations to improve anemia in patients with myelofibrosis. Srdan Verstovsek, MD, PhD, United Energy Resources, Inc. Professor of Medicine, director, Hanns A. Pielenz Clinical Research Center for Myeloproliferative Neoplasms, chief, Section...

www.onclive.com

Comments / 0

Comments / 0